GlassScriptPhysician profile
Stephen D Matthews
NPI 1982099297
$2,871.01
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $451 · 2022: $1,586 · 2023: $807 · 2024: $27.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $835.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $834.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $628.79 | 2022-2023 | Onyx Frontier |
| Baxter Healthcare | $300.81 | 2022-2023 | Hillrom - Cardiac Ambulatory Monitor |
| Cvrx, INC. | $287.78 | 2023-2024 | Barostim Neo System |
| Amgen INC. | $251.51 | 2021-2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $197.26 | 2022-2023 | Camzyos, Eliquis |
| Alnylam Pharmaceuticals INC. | $185.82 | 2021-2023 | Onpattro |
| Abiomed | $178.54 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.49 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $127.13 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $102.69 | 2022 | |
| Esperion Therapeutics, INC. | $100.01 | 2021-2023 | Nexletol |
| Sanofi-Aventis U.S. LLC | $51.53 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $49.63 | 2021-2023 | Verquvo |
| Kiniksa Pharmaceuticals, LTD. | $43.95 | 2022 | |
| Pfizer INC. | $31.80 | 2022-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $28.32 | 2021-2022 | |
| Terumo Medical Corporation | $27.53 | 2021 | |
| Kestra Medical Technology Services, INC. | $23.30 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.06 | 2023 | |
| Impulse Dynamics (USA) INC. | $19.55 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.34 | 2021 | |
| W. L. Gore & Associates, INC. | $18.80 | 2022 | |
| Amryt Pharma Holdings LTD | $15.23 | 2021 | |
| Heartflow, INC. | $12.60 | 2022 | |
| Inari Medical, INC. | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Matthews listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.